Halozyme director Henderson sells 20,000 common shares

In a regulatory filing, Halozyme director Jeffrey William Henderson disclosed the sale of 20,000 common shares of the company in two transactions of 10,000 shares each. The first set of shares was sold on February 28 at aprice of $48.51 per share, while the second set of shares was sold on March 1 at a price of $47.71 per share.